A new formable bone graft solution is now available in Europe.
ApaTech has announced the launch of Actifuse Shape, a new formable bone graft solution in Europe.
The application of pressure to, or direct warming of, Actifuse Shape makes it pliable and shapeable, meaning that it can be either placed straight into the operative site or moulded to fit it. Once formed, Actifuse Shape retains its new contours as bone healing occurs.
Actifuse Shape is 96% granules and, unlike synthetic and Demineralised Bone Matrix (DBM) Foam products, does not need to be mixed with blood or bone marrow aspirate and retains its structure as bone re-grows. The polymer dissolves away from the operative site within 48 hours.
Actifuse is a new class of synthetic bone graft and is an exceptional bone graft material. Silicate ions are used to selectively replace phosphate groups in the calcium phosphate crystal lattice. This new material accelerates the formation of bone. The resultant bone composite structure contains greater amount of natural bone as compared to traditional synthetic graft material.
The silicate substituted calcium phosphate material also displays excellent porosity at all levels, allowing for natural networking of capillaries and bone matter during formation. Actifuse combines osteoconductive and osteostimulatory activities, making it suitable for a wide range of orthopaedic and spinal applications.
Complex anatomy, such as the spine, has sometimes required bone graft materials to be formable, while retaining their core regenerative characteristics. Actifuse Shape is the first product to deliver on this expectation. Launched this year, Actifuse Shape, this formable out of the box fresh solution for bone grafting, was co-developed with Ceremed.
It merges the properties of Ceremed’s AOC Biosoluble Copolymers with Actifuse to create a highly saleable range of products, which lend themselves to easy moulding and/or cutting to the contours of the required grafting site.
Typical surgical applications for bone graft substitutes include spinal fusion, where a cage or screw fixation device is used to relieve the graft site from physiological load. It is not intended to be used in place of cortical strut allograft bone where high tensile, torsion and/or bending strength are required.
